Solving the cell therapy access problem – by reprogramming human cells
Featured in Technology Dispatch, bit.bio SVP of Technical Operations & Cell Manufacturing, Kathryn Golden, shares her insights into cell therapy.
Featured in Technology Dispatch, bit.bio SVP of Technical Operations & Cell Manufacturing, Kathryn Golden, shares her insights into cell therapy.